InvestorsHub Logo
Followers 26
Posts 1375
Boards Moderated 0
Alias Born 02/07/2010

Re: cjgaddy post# 171163

Wednesday, 04/02/2014 6:46:01 PM

Wednesday, April 02, 2014 6:46:01 PM

Post# of 346123
Question to all,

Is there anything important in the statement on Brekken's slide 2? The statement is "I will discuss off label use of Bavituximab..." I've never seen this before in any presentation. I've done some reading, and off-label is always used in reference to use of an approved drug in an unapproved way, either dosage, age group, different indication.

Why would this suddenly appear as they have been talking about using Bavi in "unapproved" indications for some time, with "unapproved" meaning in ways not being currently studied. Just seems like a strange "new" disclosure.

JBAIN
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News